Related Experiment Video
Updated: Jul 2, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Myoclonus associated with high-dose parenteral methadone
1VITAS Innovative Hospice Care, Orange County, Orange, California, USA.
Abstract:
Methadone is generally believed to be devoid of neuroexcitatory properties, and its use is increasing. This paper reports two cases of myoclonus with high-dose parenteral methadone in patients with cancer under hospice care. This side effect may be dose related and/or due to the parenteral route of administration. Reduction of the dose and change of route was sufficient to eliminate the myoclonus while maintaining an adequate pain control. Possible mechanisms for methadone causing myoclonus include a redistribution of receptor saturation in the N-methyl-D-aspartate (NMDA) and delta receptors. Ketamine may be an option for patients with intractable pain who develop methadone-induced myoclonus.
Insights
High-dose methadone, especially when injected, can cause neuroexcitation like myoclonus in cancer patients. Adjusting the dose and administration route effectively managed this side effect, offering pain relief without movement disorders.
Area of Science:
- Palliative Care
- Neuropharmacology
- Oncology
Background:
- Methadone is widely used for pain management and is generally considered non-neuroexcitatory.
- Its clinical use is expanding, necessitating a thorough understanding of its side effect profile.
Observation:
- Two cancer patients receiving high-dose parenteral methadone in hospice care developed myoclonus.
- Myoclonus, or involuntary muscle twitching, emerged as a potential adverse effect of high-dose methadone administration.
Findings:
- The observed myoclonus was potentially linked to the high dosage and/or intravenous route of methadone administration.
- Reducing the methadone dose and switching to an alternative route of administration resolved the myoclonus while maintaining effective pain control.
- Potential mechanisms involve methadone-induced redistribution of receptor saturation at N-methyl-D-aspartate (NMDA) and delta receptors.
Implications:
- This suggests that methadone may possess neuroexcitatory properties under specific conditions, challenging previous assumptions.
- Parenteral administration and high doses of methadone warrant careful monitoring for potential neuroexcitatory side effects in palliative care.
- Ketamine may serve as an alternative pharmacological option for managing intractable pain in patients experiencing methadone-induced myoclonus.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Alterations in Muscle Tone lll
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Skeletal Muscle Relaxants: Therapeutic Uses
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Drug Toxicity: Dose-Dependent Reactions

